| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 07/20/2010 | US7759314 Stabilizing collagen VI-deficient dystrophin-associated protein complexes (DAPCs) on the surface of a cell by contacting the cell with an effective amount of a biglycan therapeutic; treatment of muscular dystrophies |
| 07/20/2010 | CA2655875C Detection of antibiotics |
| 07/15/2010 | WO2010081004A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates |
| 07/15/2010 | WO2010080992A1 Regulators of the interferon-alpha receptor 1 (ifnar1) chain of the interferon receptor |
| 07/15/2010 | WO2010080835A1 Compositions and methods for the treatment or the prevention oral infections by e. coli |
| 07/15/2010 | WO2010053548A3 Pthr1 receptor compounds |
| 07/15/2010 | WO2010053546A3 Crf1 receptor compounds |
| 07/15/2010 | US20100178210 Stable protein storage and stable nucleic acid storage in recoverable form |
| 07/15/2010 | CA2749115A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates |
| 07/15/2010 | CA2747703A1 Compositions and methods for the treatment or the prevention oral infections by e. coli |
| 07/14/2010 | EP2205641A1 Method for preparing antibody monolayers which have controlled orientation using peptide hybrid |
| 07/13/2010 | US7754861 Method for purifying proteins |
| 07/13/2010 | US7754859 Targeted binding agents directed to PDGFR-alpha and uses thereof |
| 07/13/2010 | US7754851 wound closure or coverage systems, comprising employing the recombinant spider silk protein; artificial cartilage, tendon materials, automotive parts or parts used in the aircraft construction, which comprise the protein |
| 07/13/2010 | US7754241 Macromonomer for preparation of a degradable hydrogel |
| 07/13/2010 | CA2538124C Biological active coating components, coatings, and coated surfaces |
| 07/13/2010 | CA2307954C Enzyme-medicated modification of fibrin for tissue engineering |
| 07/08/2010 | US20100173788 Biomarkers for breast cancer |
| 07/08/2010 | US20100173377 N-sulfonylaminocarbonyl containing compounds |
| 07/08/2010 | US20100172968 Chimeric cannulae proteins and methods for making and using them |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172899 IgM Production by Transformed Cell and Method of Quantifying the Same |
| 07/08/2010 | CA2746228A1 Modified rsv f proteins and methods of their use |
| 07/07/2010 | EP1499888B1 Conformationally constrained peptides that bind the orl-1 receptor |
| 07/06/2010 | CA2373491C Method of detecting interacting proteins |
| 07/01/2010 | WO2010075575A1 Compositions and methods for re-programming cells without genetic modification |
| 07/01/2010 | US20100168024 Direct utilization of plasma proteins for the in vivo assembly of protein-drug/imaging agent conjugates, nanocarriers and coatings for biomaterials |
| 07/01/2010 | US20100167301 Method and device for immunoassay using nucleotide conjugates |
| 07/01/2010 | US20100166778 Toll-Like Receptor 3 Antagonists |
| 07/01/2010 | US20100166700 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation |
| 07/01/2010 | CA2748009A1 Compositions and methods for re-programming cells without genetic modification |
| 06/30/2010 | EP2200626A2 Analogues of exendin-4 and exendin-3 |
| 06/30/2010 | CN101759805A Long-acting thymosin alpha1-polyethylene glycol modifiers |
| 06/29/2010 | US7745581 T-bet compositions and methods of use thereof |
| 06/29/2010 | US7745577 cyclic peptide having amino acid sequences amidated or hydroxylated at the carboxy terminus and conjugated to a detectible agent and/or a cytotoxic agent, used for detecting tumors and preventing transformation of normal cells into tumor cells |
| 06/29/2010 | US7745576 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 06/29/2010 | US7745569 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques |
| 06/29/2010 | US7745185 Sulfotransferase 1A3 sequence variants |
| 06/29/2010 | US7745140 Cell proliferation; tissue engineering; screening, detection of antigens; immunitherapy; development of vaccine; antitumor, anticancer agents |
| 06/29/2010 | US7745126 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions. |
| 06/29/2010 | US7744906 Chaperone proteins comprising at least one of three specific nucleotide sequences; analgesics; side effect reduction; lastslonger than narcotics; relieving any type of pain |
| 06/24/2010 | WO2010071071A1 Protein-immobilized electrode and manufacturing method therefor, and functional element and manufacturing method therefor |
| 06/24/2010 | WO2010021755A3 Tau protease compositions and methods |
| 06/24/2010 | US20100160174 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 06/23/2010 | EP2198952A1 Molecule recognizing material and process for producing the molecule recognizing material |
| 06/23/2010 | EP2198301A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 06/22/2010 | US7741454 Biological low-molecular-weight derivatives |
| 06/22/2010 | US7741443 human C-type lectin; diagnosis, prevention and/or treatment of neoplastic disorders and diseases |
| 06/22/2010 | US7741439 Isolated stra6 polypeptides |
| 06/22/2010 | US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof |
| 06/22/2010 | US7740860 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 06/17/2010 | WO2010019570A3 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 06/17/2010 | US20100151472 Detection Composition |
| 06/17/2010 | US20100150954 Vaccines against influenza virus |
| 06/17/2010 | US20100150837 ANTIBODIES AGAINST GPIb alpha |
| 06/16/2010 | EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 06/16/2010 | EP2196471A1 Peptide and protein preservation method |
| 06/15/2010 | US7737251 conjugates comprising blood proteins covalently coupled to a gastrointestinal tissue growth promoter derivatives, having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders |
| 06/15/2010 | US7737116 Modified and stabilized GDF propeptides and uses thereof |
| 06/15/2010 | US7736862 screening for high affinity agonists, antagonists and inverse agonists of taste activity; Such compounds could be useful as additives in foods, beverages and drugs |
| 06/15/2010 | US7736647 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells |
| 06/15/2010 | US7736644 Monoclonal antibody for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 06/10/2010 | WO2010063122A1 Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 06/10/2010 | US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 06/10/2010 | US20100143920 Surfactant Protein D is a Biomarker for Steroid Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease |
| 06/10/2010 | US20100143884 Detection of influenza virus |
| 06/10/2010 | US20100143399 Process for manufacturing vaccines |
| 06/10/2010 | CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 06/09/2010 | EP2194383A1 Monitoring immunologic, hematologic and inflammatory diseases |
| 06/09/2010 | EP1377826B1 Opiate receptors |
| 06/09/2010 | CN101724075A Remodeling and glycoconjugation of peptides |
| 06/09/2010 | CN101250498B Method for culturing liver cell by hepatocyte-carrying growth factor polylactic acid-0-carboxymethyl shellglycan nano partical |
| 06/08/2010 | US7732575 Proteins bonded to solid supports |
| 06/08/2010 | US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein |
| 06/08/2010 | US7731995 Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal |
| 06/08/2010 | US7731970 Variants of the major allergen Phl p 1 from timothy grass |
| 06/03/2010 | WO2010060217A1 Antibody-targeted carrier for contrast agents |
| 06/03/2010 | WO2010060216A1 Nanoaggregate embedded beads conjugated to single domain antibodies |
| 06/03/2010 | WO2010060209A1 Single domain antibody - targeted nanoparticle architectures for increased pathogen detection specificity and sensitivity |
| 06/03/2010 | US20100137188 Formulations comprising cyclic compounds |
| 06/03/2010 | US20100136527 Dominant B Cell Epitopes and Methods of Making and Using Thereof |
| 06/03/2010 | CA2744384A1 Nanoaggregate embedded beads conjugated to single domain antibodies |
| 06/03/2010 | CA2744344A1 Antibody-targeted carrier for contrast agents |
| 06/01/2010 | US7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
| 06/01/2010 | US7727956 Deoxonadepsipeptides |
| 06/01/2010 | US7727550 Biologically active native biomatrix composition |
| 06/01/2010 | US7727535 Protein comprising amino acid sequence with one to 20 amino acid substitutions, deletions or insertions; lower affinity binding to alpha thrombin, lower aggregation, or proteolysis resistance; inflammation, thrombosis, atherosclerosis, angioplasty-related restenosis; cardiovascular disorders |
| 06/01/2010 | CA2115839C Hla-restricted hepatitis b virus ctl epitopes |
| 05/27/2010 | WO2010059732A1 Antiviral vaccines with improved cellular immunogenicity |
| 05/27/2010 | WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/27/2010 | US20100130721 Immobilized protein that is immobilized only at its amino terminus in orientation-controlled manner |
| 05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
| 05/25/2010 | US7723491 extracting proteinaceous growth factors from bovine through chromatography, solvent extraction, precipitation, centrifugation; biological substances purification |
| 05/25/2010 | US7723485 Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates |
| 05/25/2010 | US7723481 G protein coupled receptor (GPCR) polypeptide, attached to a detectable label seleacted from green fluorescent polypeptide or a rhodopsin polypeptide, involved in bitter taste transduction; used as additives for foods, beverages and drugs in order to modify T2R-associated bitter taste |
| 05/25/2010 | US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/25/2010 | US7723084 Protein such as chymotrypsin, cytochrome C, and trypsin covalently attached to a functionalized polymeric nanofiber; polymers used include homopolymers and copolymers of alpha olefins, alpha, beta unsaturated carboxylic acids, vinyl aromatics, ethyl ethers, nylons, polyesters, polyurethanes, and silanes |
| 05/25/2010 | US7723051 HT2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 05/25/2010 | US7723021 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases |
| 05/25/2010 | CA2248243C Purification of tissue plasminogen activator (tpa) |